CGT

97개 · ADC 890 · Antibody 4071 · CGT 2714 · 다음 갱신 D-5 · 마지막 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved97 programs
CGTLimited DatastaleBeijing GoBroad HospitalPhase 2

Autologous CD7 CAR T-cell (Autologous CD7 CAR T-cell)

T-cell Acute Lymphoblastic Leukemia; Acute Lymphoblastic Leukemia, in Relapse · FRα

#FR#CGT#Phase2#cell-gene-therapy#CAR-T+5
Trials 1Status Recruiting
CGTLimited DatastaleZhejiang UniversityPhase 1

BCMA Targeted CAR T-cells (BCMA Targeted CAR T-cells)

Relapse Multiple Myeloma; Refractory Multiple Myeloma · BCMA

#BCMA#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 1Status Active
CGTLimited DatastaleCells & Genes Biotech (Shanghai…Phase 1

BCMA-Targeted Chimeric Antigen Receptor Autologous T-cell (BCMA-Targeted Chimeric Antigen Receptor Autologous T-cell)

Relapsed/Refractory; Multiple Myeloma · BCMA

#BCMA#CGT#Phase1#cell-gene-therapy#CAR-T+5
Trials 1Status Recruiting
CGTLimited DatastaleGroupe Hospitalier Pitie-Salpet…Preclinical

CAR T-cell and Cellular Therapies (CAR T-cell and Cellular Therapies)

Adverse Drug Reactions; Cancer · Adverse Drug Reactions

#AdverseDrugReactions#CGT#Preclinical#cell-gene-therapy#CAR-T+3
Trials 1Status Active
CGTLimited DatastaleCARsgen Therapeutics Co., Ltd.Phase 1

CAR-CLDN18.2 T-Cells (CAR-CLDN18.2 T-Cells)

Advanced Solid Tumor · CLDN18.2

#CLDN182#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 1Status Active
CGTLimited DatastaleUniversity College, LondonPhase 1

CAR19 T-Cells (CAR19 T-Cells)

Diffuse Large B-Cell Lymphoma · Diffuse Large B-Cell Lymphoma

#DiffuseLargeB-CellLymphoma#CGT#Phase1#cell-gene-therapy#CAR-T+2
Trials 1Status Active
CGTLimited DatastaleGyala TherapeuticsPhase 2

CART84 (CART84)

Acute Myeloblastic Leukaemia; Leukemia, T-Cell · Acute Myeloblastic Leukaemia

#AcuteMyeloblasticLeukaemia#CGT#Phase2#cell-gene-therapy#CAR-T+4
Trials 1Status Recruiting
CGTLimited DatastaleYake Biotechnology Ltd.Phase 1

CD117 CAR T-cells (CD117 CAR T-cells)

Acute Myeloid Leukemia · Acute Myeloid Leukemia

#AcuteMyeloidLeukemia#CGT#Phase1#cell-gene-therapy#CAR-T+2
Trials 1Status Recruiting
CGTLimited DatastalePeking University People's Hosp…Phase 1

CD147- CAR T cells (CD147- CAR T cells)

T-cell Non-Hodgkin's Lymphoma · T-cell Non-Hodgkin's Lymphoma

#T-cellNon-HodgkinsLymphoma#CGT#Phase1#cell-gene-therapy#CAR-T+2
Trials 1Status Active
CGTLimited DatastaleGuangdong Zhaotai Cell Bio-tech…Phase 2

CAT19T2 (CD19 CAR T-Cell, CD19 CAR T-Cell(CAT19T2))

B-cell Acute Lymphoblastic Leukemia; B-Cell Lymphoma, Unspecified · CD19

#CD19#CGT#Phase2#cell-gene-therapy#CAR-T+5
Trials 1Status Discontinued
CGTLimited DatastaleThird Military Medical Universi…Phase 1

CD19 CAR and PD-1 knock out engineered T-cells (CD19 CAR and PD-1 knock out engineered T-cells)

Acute Lymphoblastic Leukemia; Burkitt Lymphoma · PD-1

#PD-1#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 1Status Active
CGTLimited DatastaleSabz BiomedicalsPhase 1

CD19 CAR engineered autologous T-cells (CD19 CAR engineered autologous T-cells)

Relapsed B Cell Acute Lymphoblastic Leukemia (ALL); Refractory B Cell Acute Lymphoblastic Leukemia (ALL) · CD19

#CD19#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 1Status Active
CGTLimited DatastaleSt. Jude Children's Research Ho…Phase 2

SJCAR19 product (CD19- specific CAR engineered autologous T-cells, CD19- specific CAR engineered autologous T-cells (SJCAR19 product))

Acute Lymphoblastic Leukemia, in Relapse; Acute Lymphoblastic Leukemia, Refractory · CD19

#CD19#CGT#Phase2#cell-gene-therapy#CAR-T+4
Trials 1Status Recruiting
CGTLimited DatastaleSt. Jude Children's Research Ho…Phase 1

CD19-CAR (Mem, CD19-CAR, CD19-CAR(Mem) T-cells)

Acute Lymphoblastic Leukemia, in Relapse; Acute Lymphoblastic Leukemia, Refractory · CD19

#CD19#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 1Status Recruiting
CGTLimited DatastaleMedical University of South Car…Phase 2

CD19-CD34t metabolically programmed CAR transduced T-cells (CD19-CD34t metabolically programmed CAR transduced T-cells)

B-cell Non Hodgkin Lymphoma; Chronic Lymphocytic Leukemia · CD19

#CD19#CGT#Phase2#cell-gene-therapy#CAR-T+4
Trials 1Status Recruiting
CGTLimited DatastaleUniversity College, LondonPhase 1

CD19CAR T-cells (CD19CAR T-cells)

Primary CNS Lymphoma · CD19

#CD19#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 1Status Recruiting
CGTLimited DatastaleUniversity College, LondonPhase 1

CD19CAT-41BBZ CAR T-cells (CD19CAT-41BBZ CAR T-cells)

Leukemia, Lymphoblastic, Acute, Lymphoma · CD19

#CD19#CGT#Phase1#cell-gene-therapy#CAR-T+5
Trials 1Status Recruiting
CGTLimited DatastaleHe HuangPhase 1

CD20/CD22 dual Targeted CAR T-cells (CD20/CD22 dual Targeted CAR T-cells)

Relapsed and Refractory; Lymphoid Hematological Malignancies · CD20

#CD20#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 1Status Recruiting
CGTLimited DatastaleNew York Medical CollegePhase 2

CD30 CAR T-cell (CD30 CAR T-cell)

Classical Hodgkin Lymphoma · CD30

#CD30#CGT#Phase2#cell-gene-therapy#CAR-T+3
Trials 1Status Recruiting
CGTLimited DatastaleZhejiang UniversityPhase 1

CD33 CAR T-cells (CD33 CAR T-cells)

Acute Myeloid Leukemia · CD33

#CD33#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 1Status Recruiting

3 / 5 pages

← PreviousNext →